Katalog Plus
Bibliothek der Frankfurt UAS
Bald neuer Katalog: sichern Sie sich schon vorab Ihre persönlichen Merklisten im Nutzerkonto: Anleitung.
Dieses Ergebnis aus BASE kann Gästen nicht angezeigt werden.  Login für vollen Zugriff.

Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis

Title: Recurrent ETV3::NCOA2 fusions and MAPK pathway mutations in indeterminate dendritic cell histiocytosis
Authors: Kemps, Paul G.; Woei-A-Jin, F.J. Sherida H.; Quint, Koen D.; van den Bos, Cor; Naeije, Leonie; van Laar, Jan A.M.; Bempt, Isabelle Vanden; Koudijs, Marco J.; Vorderman, Ruben H.P.; Stelloo, Ellen; Swennenhuis, Joost F.; Bruggink, Annette H.; Hebeda, Konnie M.; Scheijde-Vermeulen, Marijn A.; Diercks, Gilles F.H.; Verdijk, Robert M.; Jansen, Patty M.; Hauben, Esther; Tousseyn, Thomas; Cleven, Arjen H.G.; van Wezel, Tom; Halteren, Astrid G.S. van; Hogendoorn, Pancras C.W.
Source: ISSN:2473-9529 ; ISSN:2473-9537 ; Blood Advances, vol. 9 (3), (439-444.
Publisher Information: Elsevier
Publication Year: 2025
Subject Terms: Science & Technology; Life Sciences & Biomedicine; Hematology; CLASSIFICATION; TUMORS; 3201 Cardiovascular medicine and haematology
Description: sponsorship: The authors thank the immunohistochemical laboratory of Leiden University Medical Center for performing additional immunohistochemical stains. The authors also thank A. Beishuizen (Princess Maxima Center for Pediatric Oncology) , D.J.P. Willemsen (Anna Hospital) , A.M. van Tuyll van Serooskerken (Haga Hospital) , and D. Dittmar (University Medical Center Gro-ningen) for providing clinical data and/or images of individual patients.This study was funded by a grant from Stichting de Merel (P.G.K., T.v.W., A.G.S.v.H., and P.C.W.H.) . F.J.S.H.W.-A.-J. personally financed routine molecular diagnostic tests for her patients when these were not reimbursed. P.G.K. received an MD/PhD grant from Leiden University Medical Center. T.T. holds a Mandate for Fundamental and Translational Research from the "Stichting tegen Kanker" (2014-083 and 2019-091) and is supported by the ME TO YOU Foundation. I.V.B. is a recipient of a postdoctoral fellowship sponsored by the Clinical Council for Research and Education from University Hospitals Leuven. (Stichting de Merel, Leiden University Medical Center, ME TO YOU Foundation, Mandate for Fundamental and Translational Research from the "Stichting tegen Kanker"|2014-083, Mandate for Fundamental and Translational Research from the "Stichting tegen Kanker"|2019-091, Clinical Council for Research and Education from University Hospitals Leuven) ; status: Published
Document Type: article in journal/newspaper
File Description: application/pdf
Language: English
Relation: https://lirias.kuleuven.be/handle/20.500.12942/750441; https://doi.org/10.1182/bloodadvances.2024013696; https://pubmed.ncbi.nlm.nih.gov/39361730
DOI: 10.1182/bloodadvances.2024013696
Availability: https://lirias.kuleuven.be/handle/20.500.12942/750441; https://hdl.handle.net/20.500.12942/750441; https://lirias.kuleuven.be/retrieve/30b95d88-995f-4660-8cf3-d838a8342039; https://doi.org/10.1182/bloodadvances.2024013696; https://pubmed.ncbi.nlm.nih.gov/39361730
Rights: info:eu-repo/semantics/openAccess ; public ; https://creativecommons.org/licenses/by-nc-nd/4.0/
Accession Number: edsbas.C3E3381A
Database: BASE